𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Local drug delivery in recurrent malignant gliomas

✍ Scribed by A. Boiardi; M. Eoli; A. Salmaggi; E. Lamperti; A. Botturi; A. Solari; F. Di Meco; G. Broggi; A. Silvani

Publisher
Springer Milan
Year
2005
Tongue
English
Weight
37 KB
Volume
26
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Temozolomide in the treatment of recurre
Temozolomide in the treatment of recurrent malignant glioma
✍ Susan M. Chang; Philip Theodosopoulos; Kathleen Lamborn; Mary Malec; Jane Rabbit πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Options for chemotherapy at the time of recurrence in patients with malignant glioma are limited. The authors describe the efficacy and safety results of their institution's open‐label, compassionate‐use protocol of temozolomide for patients with recurrent malignant gliom

Intravenous BCNU and AZQ in patients wit
Intravenous BCNU and AZQ in patients with recurrent malignant gliomas
✍ W.K.A. Yung; M.I. Harris; J.M. Bruner; L.G. Feun πŸ“‚ Article πŸ“… 1989 πŸ› Springer US 🌐 English βš– 293 KB

Twenty-four patients with recurrent malignant glioma were treated with intravenous BCNU (80 mg/m2/ day x 3 days) alternating with AZQ (8 mg/mZ/day x 5 days) every 6--8 weeks. Twenty patients received two or more courses of chemotherapy, ten anaplastic astrocytomas (AA), eight glioblastomas (GBM), an